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Abstract 
The aryl hydrocarbon receptor (AhR) is a ligand-activated receptor that mediates the toxicity 
of environmental pollutants, such as 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Recently, 
it has been shown that the AhR plays a role in immune and inflammatory regulation. However, 
most of these studies are based on the activation of AhR by exogenous ligands. Therefore, in 
the present study, we addressed the role of this transcription factor, in the absent of exog-
enous ligand, on the immune response to Leishmania major infection. Our results indicate that 
inactivation of the AhR results in an alteration of the levels of several cytokines. Lymph node 
cells from infected Ahr-null animals displayed an increase in IFN and IL-12 levels, together with 
a decrease in IL-4 and IL-10 levels compared to wild-type (wt) mice. Ahr-null mice also pre-
sented higher serum levels of the pro-inflammatory cytokine TNF- prior to parasite inoc-
ulation and during infection compared to wt mice. Moreover, a 30% decrease in the popula-
tion of Treg cells was observed in Ahr-null mice. This decrease was associated with a reduction 
in Foxp3 mRNA levels. Finally, the alteration in the cytokine profile results in a better res-
olution of the L. major infection. 
Key  words:  Aryl hydrocarbon  receptor,  Inflammatory  response,  Regulatory  T  cells,  Leishmania 
major 
Introduction 
The aryl hydrocarbon receptor (AhR), a member 
of  the  basic  helix-loop-helix-PAS  (bHLH-Per- 
Arnt-Sim)  transcription  factor  family,  is  a  lig-
and-activated  receptor  that  mediates  the  toxicity  of 
environmental  pollutants,  such  as  2,3,7,8- 
tetrachlorodibenzo-p-dioxin  (TCDD)  [1,  2].  Upon 
binding to TCDD, the AhR translocates to the nucleus, 
dimerizes  with  AhR  nuclear-translocator  protein 
(ARNT),  binds  dioxin-responsive  elements  (DREs, 
also  known  as  xenobiotic-responsive  elements  or 
XREs), and upregulates the expression of a battery of 
genes  encoding  xenobiotic-metabolizing  enzymes, 
such  as  cytochrome  P450s  (CYP1A1,  CYP1A2, 
CYP1B1),  NAD(P)H  quinone  oxidoreductase,  and 
UDP-glucoronosyl-transferase-6  [3].  Although  AhR 
may  function  as  part  of  an  adaptive  chemical  re-
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sponse, several studies have suggested that this tran-
scription  factor  could  have  important  functions  in 
liver and cardiac development, cell proliferation, cir-
cadian rhythmicity, cholesterol and glucose metabo-
lism  [3-6],  and  more  recently,  in  the  ubiqui-
tin-proteasome system [7]. 
Several studies have demonstrated that AhR is 
also implicated in immune system regulation. It has 
been shown that TCDD suppresses both humoral and 
cellular immunity and induces the expression of sev-
eral cytokines, such as IL-1, IL-8, and IL-6 [8]. In ad-
dition  to  TCDD,  other  environmental  contaminants 
that  activate  AhR,  such  as  benzo[a]pyrene,  dime-
thylbenzanthracene,  and  3-methylcholanthrene,  in-
duce immunotoxicity [9]. Targeting AhR results in the 
disruption  of  the  immune  system  by  decreasing 
lymphocyte  accumulation  in  the  spleen  and  lymph 
nodes and overriding the thymic atrophy induced by 
TCDD  [4,  10].  Besides  that,  lipoxin  (LX)-A4,  an  an-
ti-inflammatory molecule, acts as an endogenous AhR 
ligand [11]. More recently, we have shown that lym-
phocytes from Ahr-null mice produce more IFN and 
IL-12 than lymphocytes from wild-type (wt) animals 
[12].  These  studies  suggest  that  AhR  plays  an  im-
portant  role  in  immune  system  homeostasis;  there-
fore, the activation status of AhR may modulate the 
immune system response to an infection and/or im-
mune  pathology  development.  AhR  is  required  for 
optimal resistance to a Listeria monocytogenes infection 
in certain animal models [13]. AhR is also involved to 
resistance to Streptococcus pneumoniae infection when 
activated by TCDD [14], and it modulates anti-viral 
immunity [15]. More recently, we showed that AhR 
plays an important role in the inflammatory response 
to Toxoplasma gondii [16]. To further determine the role 
of  AhR  in  immune  responses,  we  infected  wt  and 
Ahr-null mice with Leishmania major, an intracellular 
parasite that causes a well-characterized immune re-
sponse that is mostly associated with the induction of 
a Th1-type immune response [17]. After infection, we 
evaluated several immune endpoints. An exacerbated 
inflammatory response was observed in the Ahr-null 
mice, as evidenced by increased swelling and proin-
flammatory cytokine production when compared to 
the response of the wt mice to the infection. Our data 
also indicate that AhR is a regulatory molecule that 
plays a role in the activation of T cells and in the in-
duction of regulatory T (Treg) cells. 
Materials and Methods 
Animals. The generation of Ahr-null mice from 
C57BL/6 mice with a disruption in AhR exon 1 has 
been previously described [10]. The animals used in 
this study were Ahr-null and wt male siblings. Mouse 
breeding and genotyping by PCR were performed as 
reported elsewhere [12], and wt littermates were used 
as control mice. All animal studies were performed 
according to the Guide for the Care and Use of La-
boratory  Animals,  as  adopted  and  promulgated  by 
the U.S. National Institutes of Health and the Mexican 
Regulation  of  Animal  Care  and  Maintenance 
(NOM-062-ZOO-1999, 2001). 
Infection with Leishmania major and L. major 
antigen  preparation.  L.  major  promastigotes  (LV39 
strain) were obtained from the macerates of infected 
tissue obtained from wt mice and were differentiated 
by  culturing  in  complete  Schneider’s  medium  for  3 
days at 37 ºC. For in vivo infection, 3 x 106 stationary 
phase  L. major  promastigotes  were  injected  into  the 
footpad of the right back leg of each animal, and the 
left  back  leg  was  inoculated  with  sterile  phosphate 
balanced  saline  solution  (PBS)  as  a  control.  Lesion 
development was measured using a dial gauge mi-
crometer (Mitutoyo, Kanawa, Japan) at weekly inter-
vals up to 8 weeks after inoculation. The increase in 
the thickness of the right hind footpad was compared 
to the uninfected left hind footpad.  
L. major  antigen  was  prepared  from  stationary 
phase  promastigotes  grown  in  vitro.  Promastigotes 
were washed twice in sterile ice-cold PBS by centrif-
ugation at 200 x g for 10 min at 4 °C. Pellets were then 
frozen  in  liquid  nitrogen  and  thawed  at  37  °C  for 
seven  cycles.  Protein  concentration  was  determined 
by the Lowry assay.  
Quantification  of  parasite  loads.  Mice  were 
sacrificed 8 weeks after infection and parasite burdens 
were determined by homogenizing footpads of indi-
vidual mice and carrying out limiting dilution analy-
sis. Briefly, the footpads were excised and homoge-
nized  in  Schneider’s  insect  medium  supplemented 
with 20% fetal calf serum (FCS), 2 mM L-glutamine, 
100 U/ml penicillin, and 100 mg/ml streptomycin. To 
estimate the relative parasite load, 200 ml aliquots of 
the cell suspension (in consecutive 10-fold dilutions) 
were  added  to  the  wells  of  a  96-well  flat-bottomed 
tissue culture plate in triplicate and were incubated at 
28  ºC  for  72  h.  After  incubation,  the  cultures  were 
examined for the presence of promastigotes using an 
inverted  microscope.  The  results  were  expressed  as 
mean  parasite  titers,  using  the  dilution  where  no 
parasites were found and calculating back the amount 
of parasites present in each footpad.  
Serum antibody titers. Blood samples were ob-
tained from the tail vein, and sera were kept at -70 ºC 
until use. ELISA plates (Nunc Maxisorb, USA) were 
coated with L. major antigens (50 g/mL in PBS, pH 
9.0), and serial dilutions (1:50, 1:100, 1:500, etc.) of the 
sera were incubated for 2 h at 37 ºC. The samples were Int. J. Biol. Sci. 2011, 7 
 
http://www.biolsci.org 
1222 
incubated  with  specific  goat  anti-IgG  (IgG1,  and 
IgG2a) HRP conjugates (Zymed, USA) for 1 h at 37 ºC. 
A  substrate  solution  containing  2,2’-azino-bis(3- 
ethylbenzthiazoline)-6-sulfonic  acid  (ABTS;  Sig-
ma-Aldrich, USA) and H2O2 (Merck, Germany) was 
added, and the absorbance was determined at 450 nm 
using a microplate reader. The antibody titer of the 
sera  was  calculated  by  identifying  the  dilution  at 
which  no  L.  major  specific  antibody  was  detected 
(endpoint titer).  
Lymph node cells. After sacrifice, the inguinal 
draining  lymph  nodes  were  collected.  A  single-cell 
suspension of lymph node cells was prepared for each 
mouse  and  immediately  used  for  the  respective 
measurements. 
Cytokine  and  LXA4  measurement.  Serum  or 
culture supernatant samples were used to assess cy-
tokine levels by the sandwich ELISA method, as pre-
viously described [18]. Total cytokine levels were de-
termined  using  paired  monoclonal  antibodies.  All 
antibodies and recombinant proteins were purchased 
from Peprotech (Mexico). LXA4 levels were measured 
using a competition EIA kit (Oxford Biomedical Re-
search,  EA45,  England)  following  the  kit’s  instruc-
tions. Standard curves were plotted as the standard 
cytokine  protein  concentration  (pg/ml)  versus  the 
corresponding mean optical density (O.D.) value of 
the replicates. The concentrations of the putative cy-
tokine-containing samples were quantified based on 
the standard curve. 
Identification  of  Treg  cells.  Flow  cytometric 
analysis of Treg cells was performed using a staining 
kit (Mouse Treg FlowTM Kit, BioLegend, San Diego, 
CA) as follows: 1 x 106 cells in wash buffer (DPBS with 
1% sodium azide and 1% FCS) were stained with 1 l 
of  anti-CD4-fluorescein  isothiocyanate,  anti-CD25- 
phycoerythrin,  and  anti-Foxp3-Alexa  Fluor  488,  ac-
cording to the manufacturer’s instructions. The cells 
were fixed, and the proportion of cells that were posi-
tive  for  all  three  markers  was  evaluated  (10,000 
events/sample) with a flow cytometer (Becton Dick-
inson, USA). Non-specific binding was blocked with 
FcBlock, and the isotype controls were rat anti-mouse 
IgG-FITC, IgG-PE, or IgG-Alexa Fluor 488. Treg cells 
were identified by positive staining of activated CD4+ 
cells (CD25+ expression on the CD4+ population) and 
further expression of intracellular Foxp3. 
PCR  analysis  of  mRNA  expression.  Lymph 
node cells were collected, resuspended in Trizol rea-
gent  (Sigma-Aldrich),  and  processed  to  obtain  total 
RNA.  cDNA  synthesis  was  performed  with  Super-
Script One-Step Reverse Transcription-PCR Kit (Invi-
trogen). In brief, 3 g of total RNA was mixed with 0.5 
µg oligo (dT) 12 to -18 primers, 10 mM of each dNTP 
and  1x  reaction  buffer  in  a  final  volume  of  20  µl. 
cDNA reactions were incubated at 65 °C for 10 min to 
denature the RNA template and were quench-cooled 
for 1 min. Reverse transcriptase (0.5 l) was added, the 
samples were incubated at 42 °C for 50 min and 70 °C 
for  15  min,  0.5  l  of  RNaseH  was  added,  and  the 
samples were further incubated for 15 min at 36 °C. 
cDNA samples were amplified for 30 cycles using Taq 
polymerase (Invitrogen) and specific primers (Table 
1). After amplification, PCR products were separated 
by gel electrophoresis on 1.5% agarose gels containing 
ethidium  bromide,  a  nucleic  acid  gel  stain  used  at 
1000X  (Amresco),  and  were  visualized  with  the 
FLA-5000 chemiluminescence detection system (Fuji-
film). The data were normalized to 18rS expression 
and  were  analyzed  using  the  Multi-Gauge  Image 
program. All reactions were repeated three times to 
ensure reproducibility. 
Statistical  analyses.  The  statistical  significance 
of the data was evaluated using the non-parametric 
Mann-Whitney U test, Wilcoxon rank test or Student’s 
t-test, as appropriate. In all cases, differences between 
animal groups were considered to be statistically sig-
nificant if p < 0.05 (*). 
 
Table 1. Primer sequences and PCR conditions for gene expression analyses. 
Gene 
(oC) 
 
Oligonucleotide sequence (5´-3´) 
 
 
Annealing  
 
 
Cycles 
 
Product size (bp) 
 
Foxp3 
 
 
F: GGCCCTTCTCCAGGACAGA  56 
 
 
30 
 
 
112  
 
  R: GCTGATCATGGCTGGGTTGT 
 IL-17 
 
 
F: TGGCGGCTACAGTGAAGGCA  56 
 
 
30 
 
 
400  
 
  R: ACAATCGAGGCCACGCAGGT 
18rS 
 
F: GGACAGGATTGACAGATTGATAG  60 
 
30 
 
100 
  R: CTCGTTCGTTATCGGAATTAAC 
F: Forward, R: Reverse Int. J. Biol. Sci. 2011, 7 
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Results 
Exposure  to  polycyclic  aromatic  hydrocarbons 
(PAHs)  can  result  in  immune  system  alterations  in 
both the innate and adaptive immune system. These 
compounds  share  a  common  signaling  mechanism: 
the AhR. Therefore, in the present study, we evalu-
ated the role of AhR in the immune response to  L. 
major infection.  
L.  major  promastigotes  were  injected  into  the 
footpads of wt and Ahr-null mice. One week after the 
infection, the inflammatory process was initiated in 
both  wt  and  Ahr-null  mice,  although  inflammatory 
intensity was higher and started earlier in the Ahr-null 
mice. Four weeks later, inflammation declined earlier 
in the Ahr-null mice compared to wt mice (Fig. 1A). 
The  final  outcome  of  L.  major  infection  was  deter-
mined by evaluating parasite numbers in the lesions 6 
weeks after infection. Ahr-null mice presented a de-
crease in the number of parasites in the footpad le-
sions when compared to wt mice (Fig. 1B). These dif-
ferences may be explained by the initial exacerbated 
inflammatory response observed in Ahr-null mice. 
Because  inflammatory  processes  are  mediated 
by  cytokines,  we  examined  several  pro-  and  an-
ti-inflammatory  factors  during  the  infection.  Blood 
samples  were  obtained  every  two  weeks  for  two 
months, and the levels of TNF, IL-12, IL-10 and LXA4 
were measured. Ahr-null mice presented higher levels 
of the pro-inflammatory cytokine TNF- when com-
pared to wt mice, both prior to parasite inoculation 
and during infection (Fig. 2A). 
During the first four weeks of infection, the wt 
mice contained lower levels of IL-10 than the Ahr-null 
mice (Fig. 2C). In contrast, serum IL-12 levels were 
higher  in  the  wt  animals  compared  to  the  Ahr-null 
mice during the same period (Fig. 2B). Ahr-null mice 
displayed a decrease in IL-10 levels and an increase in 
IL-12 levels at four and six weeks post-infection, re-
spectively. The opposite was observed in wt mice, in 
which an increase in IL-10 levels and a decrease in 
IL-12 levels were apparent at six weeks post-infection 
(Figs.  2B  and  C).  The  levels  of  LXA4,  an  an-
ti-inflammatory  molecule,  were  higher  in  wt  mice 
before parasite inoculation and during the infection 
compared  to  Ahr-null  mice.  In  both  animals,  a 
time-dependent increase in LXA4 levels was observed 
(Fig.  2D).  To  more  completely  characterize  the  im-
mune  response  to  L. major,  specific  IgGs  (IgG1  and 
IgG2a) were quantified at 3 weeks post-infection. As 
shown  in  Fig.  3,  Ahr-null  mice  presented  a  higher 
proportion of the endpoint titer of IgG1/IgG2a com-
pared to wt animals. 
To  further  characterize  the  immune  response, 
lymph node cells from infected wt and Ahr-null mice 
were  cultured  with  L.  major  antigen,  and  cytokine 
levels were determined. IFN- levels were higher in 
Ahr-null  lymph  node  cells  compared  to  wt  cells  at 
baseline. IL-12 levels were higher in Ahr-null lymph 
node cells when compared to wt cells after exposed to 
L. major antigen (Figs. 4A  and 4B). In 
contrast,  the  levels  of  the  an-
ti-inflammatory  cytokines  IL-4  and 
IL-10 were decreased in Ahr-null cells 
compared to lymph node cells from wt 
mice (Figs. 4C, and 4D). 
 
 
 
 
Figure 1. Progression of L. major lesions in 
wt and Ahr-null mice. Promastigotes were 
injected into the footpads of the mice, as 
described  in  the  Materials  and  Methods. 
Progression  of  the  lesion  growth  in  the 
footpads was measured based on the mean 
lesion size every week (A), and the number 
of parasites present in the lesion was de-
termined after eight weeks (B). Mean ± SD 
(n = 15), *p<0.05, Mann-Whitney U test. 
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Figure 2. Inflammatory-related factors after infection with L. major. Blood samples were collected from the tail veins of the 
mice every two weeks, and the levels of TNF- (A), IL-12 (B), IL-10 (C), and lipoxin A4 (D) were measured in the serum, as 
described in the Materials and Methods. Mean ± SD (n = 15), *p<0.05, Mann-Whitney U test. 
 
 
Figure 3. Antibody response in wt and Ahr-null mice. The production of L. major-specific IgG1/IgG2a is presented as re-
ciprocal endpoint titers. These titers were determined after 3 weeks of infection in serum collected from the tail vein. Mean 
± SD (n = 5), *p<0.05, Student’s t-test. Int. J. Biol. Sci. 2011, 7 
 
http://www.biolsci.org 
1225 
 
Figure 4. Cytokine profile of lymph node cells from infected animals. Lymph nodes from wt and Ahr-null mice were col-
lected after six weeks, and the cells were cultured with L. major antigen. After five days of culture, levels of IFN-γ (A), IL-12 
(B), IL-4 (C) and IL-10 (D) in the supernatants were measured by sandwich ELISA. Mean ± SD (n = 10), *p<0.05, Student’s 
t-test. 
 
Because inflammatory responses are also mod-
ulated by T regulatory (Treg) lymphocytes, we asked 
whether  Ahr-null  mice  exhibited  altered  Treg  cell 
counts. Lymphocytes from the draining lymph node 
were obtained at different time points post-infection, 
and the CD4+/CD25+/Foxp3+ lymphocyte subpop-
ulation was evaluated by flow cytometry. As shown 
in Fig. 5C, at four weeks after infection, a slight but 
significant  decrease  in  Treg  cells  was  observed  in 
Ahr-null compared to wt mice, and the decrease was 
more  evident  after  six  weeks  (30%  decrease  in 
Ahr-null Treg cells compared to those of wt mice). We 
also  observed  an  inverse  pattern  between  Ahr-null 
and  wt  mice  in  the  induction  of  activated  Th  cells. 
Ahr-null mice presented significantly lower numbers 
of activated Th cells during the first two weeks of in-
fection.  By  four  and  six  weeks  post-infection,  this 
profile was reversed, and the Ahr-null mice displayed 
higher numbers of activated Th cells compared to wt 
mice (Fig. 5B). 
The  differentiation  of  T  cells  into  Treg  cells  is 
modulated  by  the  presence  of  Foxp3  and  IL-17; 
therefore, the levels of Foxp3 and IL-17 mRNA from 
lymph  node  cells  were  determined.  Ahr-null  cells 
presented  lower  levels  of  Foxp3  mRNA  before  the 
infection  and  two  weeks  after  the  infection  when 
compared to lymph node cells from wt mice (Fig. 6A). 
In contrast, wt cells presented lower levels of IL-17 
mRNA  before  the  infection  and  four  weeks 
post-infection (Fig. 6B). 
Discussion 
Several studies have suggested that AhR plays a 
role in immune and inflammatory regulation. How-
ever, most of these studies are based on AhR activa-
tion by exogenous ligands, such as TCDD [8, 14, 19]. 
In the present study, we addressed the endogenous 
role of this transcription factor, in the absence of ex-
ogenous ligand, on the immune response to L. major 
infection. Int. J. Biol. Sci. 2011, 7 
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As expected, C57BL/6 wt mice presented a Th1 
immune  response  after  infection,  and  high  serum 
levels of IL-12 and low or absent serum levels of IL-10 
were  observed  at  the  beginning  of  the  infection.  In 
contrast, AhR-null mice developed a mixed immune 
response with lower levels of IL-12 and higher levels 
of IL-10 and TNF-. The proportional distribution of 
the  IgG1  and  IgG2  serum  isotypes,  determined  at 
three weeks post-infection, indicated that the AhR-null 
mice tended to develop a Th2 immune response after 
L. major infection. The higher IgG1/IgG2a proportion 
observed in Ahr-null mice might be a result of lower 
IL-12  levels  because  this  cytokine  enhances  IgG2 
production, but it reduces IgG1 levels [20]. 
 
 
 
Figure 5. Levels of Th and Treg cells from wt and Ahr-null mice. Cells from drained lymph nodes of infected wt and Ahr-null 
mice were collected and stained for Treg-specific markers, as described in the Materials and Methods. The cells were 
evaluated for the expression of CD4, CD25, and Foxp3 by flow cytometry. Representative flow cytometric analysis of the 
CD4+CD25+Foxp3+ cells (A). The proportion of CD25+ Th cells from the total of lymph node cells (B) and the percentage 
of Treg cells from the double positive population (C) were determined at different time points after infection with L. major. 
Mean ± SD in triplicate (n = 5), *p<0.05, Student’s t-test. 
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Figure 6. Levels of Foxp3 and IL-17 mRNA from wt and 
Ahr-null lymph node cells. Expression of Foxp3 (A) and 
IL-17 (B) is normalized to the relative expression of 18rS in 
lymph node cells. Mean ± SD in triplicate (n = 5), *p<0.05, 
Student’s t-test. 
 
Initially,  the  inflammatory  process  was  more 
pronounced in the AhR-null mice, which may account 
for the decreased number of parasites in the footpad 
lesions when compared to wt mice. This may be due 
to  high  levels  of  the  pro-inflammatory  cytokine 
TNF-. The role of TNF- in leishmaniasis has been 
studied previously; inactivation of this cytokine leads 
to  aggravation  of  the  infection,  whereas  TNF- 
treatment  results  in  the  amelioration  of  the  disease 
[21, 22]. 
Consistent  with  the  present  results,  a  recent 
study showed that smoke-induced lung inflammation 
is  two-  to  three-fold  more  severe  in  Ahr-null  mice 
compared to wt mice. Moreover, the authors reported 
that  untreated  Ahr-null  mice  expressed  three-  to 
five-fold higher levels of pro-inflammatory cytokines 
(including TNF-) than wt mice [23]. In addition, AhR 
ligands, such as benzo[a]pyrene, have been shown to 
markedly diminish TNF- secretion by monocytes [9]. 
All together, these data suggest that AhR negatively 
controls TNF- expression and/or secretion, indicat-
ing that the levels of this cytokine are increased when 
AhR is not functional. The mechanism by which AhR 
affects  TNF-  expression  is  not  well  understood. 
However, because TNF- is regulated by NF-B [24], 
and AhR and NF-B can regulate the activity of one 
another [25], AhR could act as a negative modulator 
of cytokine expression via its interaction with NF-B. 
This idea is supported by the demonstration that lung 
cells from Ahr-null mice presented higher NF-B ac-
tivity compared to wt mice [23]. Moreover, the func-
tional interaction between AhR, RelB and RelA NF-B 
subunits has been previously shown [26, 27].  
Conversely, it has been shown by several groups 
that TNF- is capable of eliciting IL-10 release in an 
autoregulatory feedback loop [28-30]. Therefore, the 
high serum levels of IL-10 present in AhR-null mice 
might  be  the  result  of  the  high  TNF-levels.  Con-
sistent  with  these  results,  high  levels  of  IL-10 
down-regulate the production of IL-12 [31, 32]. 
During  an  inflammatory  response,  compensa-
tory mechanisms are also activated, such as the syn-
thesis of lipoxins. In particular, LXA4, which possesses 
significant  anti-inflammatory  activity,  has  been 
shown  to  inhibit  TNF-  production  and  activity 
[33-35].  In  the  present  study,  we  evaluated  serum 
LXA4 levels. Our results show a constant increase in 
LXA4 serum concentrations as the infection progresses 
in both wt and Ahr-null animals. This response may 
contribute  to  the  decreased  TNF-  levels  observed 
after two weeks of infection. However, the AhR-null 
mice presented lower levels of LXA4 compared to the 
wt mice. It has been reported that TCDD, the most 
potent AhR ligand, increases the expression of prostaglan-
din  endoperoxide  H  synthase  (PGHS)-2  in  an 
AhR-dependent manner [36, 37]. Additionally, the inhibi-
tion  of  (PGHS)-2  results  in  a  reduction  of 
15-hydroxyeicosatetraenoic  acid  synthesis  by  ap-
proximately  50%,  thereby  decreasing  15-epi-LXA4, 
which provides 88% of the total amount of LXA4 [38]. 
Therefore, these data, together with our present re-
sults, suggest that the AhR might be implicated in the 
synthesis of LXA4, possibly through the regulation of 
PGHS-2  gene  transcription  as  previously  demon-
strated in some human cells [39].  
After six weeks of infection, a Th1 response de-
veloped in the AhR-null mice, as the serum cytokine 
profiles  indicate.  This  response  correlates  with  the 
high IFN- and IL-12 levels and the low levels of IL-4 
and IL-10 secretion produced by the AhR-null lymph 
node cells. Moreover, the polarization of the response 
is more pronounced in the AhR-null cells than in the 
wt cells. 
At  four  and  six  weeks  post-infection,  Ahr-null 
lymph  node  cells  presented  higher  levels  of Int. J. Biol. Sci. 2011, 7 
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CD4+CD25+ cells and lower levels of Treg cells com-
pared to wt cells. During an infection, Treg cells play 
an important role in controlling immune responses by 
diminishing  potentially  damaging  effects  to 
self-tissues that can result from an uncontrolled exac-
erbated  immune  response.  Together  with  the  high 
TNF- levels, the decreased number of Treg cells found 
in  Ahr-null  mice  could  contribute  to  the  robust  in-
flammation and the increased elimination of parasite 
burden. Similar to the present study, it has been re-
ported that the C57BL/6 mice carrying an allele cod-
ing for an Ahr molecule with reduced affinity for its 
ligands  (Ahrd  mice)  presented  lower  levels  of 
CD4+Foxp3+ T cells [40]. Mutations in Foxp3, a tran-
scription factor, have been shown to impair Treg activ-
ity  [41],  and  more  recently,  it  has  been  shown  that 
AhR regulates Treg and Th17 differentiation in a lig-
and-specific manner [40]. The same authors demon-
strated  that  this  regulation  is  mediated  by  AhR 
through the control of Foxp3 expression. As with this 
study,  a  decrease  in  Foxp3  mRNA  levels  was  ob-
served in Ahr-null lymph node cells when compared 
to wt cells before infection. Consistent with the nega-
tive regulation of Treg and Th17 cells, Ahr-null mice 
presented higher levels of IL-17 mRNA. After infec-
tion, the increase in Foxp3 mRNA levels was accom-
panied  by  a  decrease  in  IL-17  mRNA  levels.  These 
results also indicate that factors other than AhR are 
involved in Foxp3 regulation. 
In conclusion, our present findings demonstrate 
that  AhR  disruption  results  in  altered  immune  re-
sponses to L. major infection; in particular, loss of Ahr 
results  in  lowered  Treg  cell  levels,  increased  TNF- 
levels, and a modified timeframe of IL-10 and IL-12 
secretion. Our results also show that AhR may play an 
important role in immune response modulation and 
suggest the presence of an endogenous ligand. Addi-
tional  experiments  are  needed  to  fully  understand 
and  clarify  the  potential  epigenetic  mechanisms  by 
which AhR functions, such as an AhR/NF-B inter-
action. Finally, our results also identify the AhR as a 
promising pharmacological target for the treatment of 
certain autoimmune and immunosuppressive diseas-
es.  
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